ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 218 filers reported holding ALKERMES PLC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $388,120 | -11.2% | 12,400 | -20.0% | 0.07% | +2.9% |
| Q1 2023 | $436,945 | +7.9% | 15,500 | 0.0% | 0.07% | +4.5% |
| Q4 2022 | $405,015 | +17.1% | 15,500 | 0.0% | 0.07% | +10.0% |
| Q3 2022 | $346,000 | -25.1% | 15,500 | 0.0% | 0.06% | -25.0% |
| Q2 2022 | $462,000 | +13.2% | 15,500 | 0.0% | 0.08% | +1.3% |
| Q1 2022 | $408,000 | +13.0% | 15,500 | 0.0% | 0.08% | 0.0% |
| Q4 2021 | $361,000 | -24.5% | 15,500 | 0.0% | 0.08% | -24.8% |
| Q3 2021 | $478,000 | -37.1% | 15,500 | -50.0% | 0.10% | -33.1% |
| Q2 2021 | $760,000 | – | 31,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |